Lyomark is specialised in niche proprietary and generic products and orphan drugs for rare diseases, presented as sterile injectable, lyophilized formulations in pre-filled syringes, vials and ampoule's. Lyomark is active in the area of respiratory disease, oncology, metabolism etc.
Related Categories
Sales Markets
Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Meet us at
CPhI Worldwide 2021
Fiera Milano, Milan, Italy
31 August - 2 September 2021
Book a meetingView Our Exhibitor Profile
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation